Knowledge domain and emerging trends in Alzheimer's disease: A scientometric review based on CiteSpace analysis

Neural Regeneration Research

Volumn 14, Issue 9, 2019, Pages 1643-1650

  Liu, Shuo ^a   Sun, Ya Ping ^a   Gao, Xu Ling ^a   Sui, Yi ^b  

^a Fourth People's Hospital of Shenyang   (China)

^b Shenyang First People's Hospital   (China)

Author keywords

Alzheimer's disease; CiteSpace; mapping knowledge domain; nerve regeneration; neural regeneration; neuroprotection; Web of Science

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; APOLIPOPROTEIN E; BETA SECRETASE; NEUROTRANSMITTER; NEUROTROPHIN; TAU PROTEIN;

AGE; ALZHEIMER DISEASE; ARTICLE; CEREBROSPINAL FLUID EXAMINATION; CITATION ANALYSIS; CLINICAL TRIAL (TOPIC); CYTOLOGY; DEMENTIA; DISEASE COURSE; DISORDERS OF CHOLESTEROL METABOLISM; DISORDERS OF MITOCHONDRIAL FUNCTIONS; EXCITOTOXICITY; GENE EXPRESSION; GENETIC ANALYSIS; HUMAN; IMMUNIZATION; INFLAMMATION; INSULIN SIGNALING; MICROGLIA; MILD COGNITIVE IMPAIRMENT; MISSENSE MUTATION; NERVE CELL NETWORK; NERVOUS SYSTEM FUNCTION; NEUROIMAGING; NEUROPATHOLOGY; NEUROPSYCHOLOGICAL TEST; OXIDATIVE STRESS; PATHOGENESIS; PATHOLOGY; PROTEOMICS; PUBLICATION; QUALITY CONTROL; TREND STUDY; VASCULAR DISEASE; WEB OF SCIENCE;

EID: 85065824327     PISSN: 16735374     EISSN: 18767958     Source Type: Journal    
DOI: 10.4103/1673-5374.255995     Document Type: Article

References (41)

1. Abud EM, Ramirez RN, Martinez ES, Healy LM, Nguyen CHH, Newman SA, Yeromin AV, Scarfone VM, Marsh SE, Fimbres C, Caraway CA, Fote GM, Madany AM, Agrawal A, Kayed R, Gylys KH, Cahalan MD, Cummings BJ, Antel JP, Mortazavi A (2017) iPSC-derived human microglia-like cells to study neurological diseases. Neuron 94:278-293 e279.
2. Albert MS, DeKosky ST, Dickson D, Dubois B, Feldman HH, Fox NC, Gamst A, Holtzman DM, Jagust WJ, Petersen RC, Snyder PJ, Carrillo MC, Thies B, Phelps CH (2011) The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 7:270-279.
3. Alzheimer A (1907) Über eine eigenartige Erkrankung der Hirnrinde. Allgemeine Zeitschrift für Psychiatrie und Psychisch-Gerichtlich Medizin 64:146-148.
4. Arber C, Lovejoy C, Wray S (2017) Stem cell models of Alzheimer's disease: progress and challenges. Alzheimers Res Ther 9:42.
5. Avramopoulos D (2009) Genetics of Alzheimer's disease: recent advances. Genome Med 1:34.
6. Berchtold NC, Cotman CW (1998) Evolution in the conceptualization of dementia and Alzheimer's disease: Greco-Roman period to the 1960s. Neurobiol Aging 19:173-189.
7. Brunholz S, Sisodia S, Lorenzo A, Deyts C, Kins S, Morfini G (2012) Axonal transport of APP and the spatial regulation of APP cleavage and function in neuronal cells. Exp Brain Res 217:353-364.
8. Chen C (2004) Searching for intellectual turning points: progressive knowledge domain visualization. Proc Natl Acad Sci U S A 101 Suppl 1:5303-5310.
9. Chen C (2006) CiteSpace II: detecting and visualizing emerging trends and transient patterns in scientific literature. J AM Soc Inf Sci Tec 57:359-377.
10. Chen C, Chen Y, Horowitz M, Hou H, Liu Z, Pellegrino D (2009) Towards an explanatory and computational theory of scientific discovery. J Informetr 3:191-209.
11. Cummings JL, Morstorf T, Zhong K (2014) Alzheimer's disease drug-development pipeline: few candidates, frequent failures. Alzheimers Res Ther 6:37.
12. Duncan T, Valenzuela M (2017) Alzheimer's disease, dementia, and stem cell therapy. Stem Cell Res Ther 8:111.
13. Fan X, Sun D, Tang X, Cai Y, Yin ZQ, Xu H (2014) Stem-cell challenges in the treatment of Alzheimer's disease: a long way from bench to bedside. Med Res Rev 34:957-978.
14. Freeman C (1978) Centrality in social networks conceptual clarification. Soc Networks 1:25.
15. Games D, Adams D, Alessandrini R, Barbour R, Berthelette P, Blackwell C, Carr T, Clemens J, Donaldson T, Gillespie F, et al. (1995) Alzheimer-type neuropathology in transgenic mice overexpressing V717F beta-amyloid precursor protein. Nature 373:523-527.
16. Goate A, Chartier-Harlin MC, Mullan M, Brown J, Crawford F, Fidani L, Giuffra L, Haynes A, Irving N, James L, et al. (1991) Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 349:704-706.
17. Gorelick PB, Scuteri A, Black SE, Decarli C, Greenberg SM, Iadecola C, Launer LJ, Laurent S, Lopez OL, Nyenhuis D, Petersen RC, Schneider JA, Tzourio C, Arnett DK, Bennett DA, Chui HC, Higashida RT, Lindquist R, Nilsson PM, Roman GC, et al. (2011) Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the American heart association/American stroke association. Stroke 42:2672-2713.
18. Harold D, Abraham R, Hollingworth P, Sims R, Gerrish A, Hamshere ML, Pahwa JS, Moskvina V, Dowzell K, Williams A, Jones N, Thomas C, Stretton A, Morgan AR, Lovestone S, Powell J, Proitsi P, Lupton MK, Brayne C, Rubinsztein DC, et al. (2009) Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease. Nat Genet 41:1088-1093.
19. Hebert LE, Weuve J, Scherr PA, Evans DA (2013) Alzheimer disease in the United States (2010-2050) estimated using the 2010 census. Neurology 80:1778-1783.
20. Heilbronner (1900) Concerning the relation between Alzheimer's disease and aphasia. Archiv fur Psychiatrie und Nervenkrankheiten 33:366-391.
21. Holtzman DM, Morris JC, Goate AM (2011) Alzheimer's disease: the challenge of the second century. Sci Transl Med 3:77sr1.
22. Lambert JC, Heath S, Even G, Campion D, Sleegers K, Hiltunen M, Combarros O, Zelenika D, Bullido MJ, Tavernier B, Letenneur L, Bettens K, Berr C, Pasquier F, Fiévet N, Barberger-Gateau P, Engelborghs S, De Deyn P, Mateo I, Franck A, et al. (2009) Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease. Nat Genet 41:1094-1099.
23. Lazarov O, Demars MP (2012) All in the family: how the APPs regulate neurogenesis. Front Neurosci 6:81.
24. Lee VM, Brunden KR, Hutton M, Trojanowski JQ (2011) Developing therapeutic approaches to tau, selected kinases, and related neuronal protein targets. Cold Spring Harb Perspect Med 1:a006437.
25. McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR, Jr., Kawas CH, Klunk WE, Koroshetz WJ, Manly JJ, Mayeux R, Mohs RC, Morris JC, Rossor MN, Scheltens P, Carrillo MC, Thies B, Weintraub S, Phelps CH (2011) The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 7:263-269.
26. Palop JJ, Mucke L (2010) Amyloid-beta-induced neuronal dysfunction in Alzheimer's disease: from synapses toward neural networks. Nat Neurosci 13:812-818.
27. Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E (1999) Mild cognitive impairment: clinical characterization and outcome. Arch Neurol 56:303-308.
28. Prince M, Wimo A, Guerchet M, Ali GC, Wu YT, Prina M (2015) World Alzheimer Report 2015. The Global Impact of Dementia. London: Alzheimer's Disease International (ADI).
29. Querfurth HW, LaFerla FM (2010) Alzheimer's disease. N Engl J Med 362:329-344.
30. Reitz C, Brayne C, Mayeux R (2011) Epidemiology of Alzheimer disease. Nat Rev Neurol 7:137-152.
31. Scheltens P, Blennow K, Breteler MM, de Strooper B, Frisoni GB, Salloway S, Van der Flier WM (2016) Alzheimer's disease. Lancet 388:505-517.
32. Schenk D, Barbour R, Dunn W, Gordon G, Grajeda H, Guido T, Hu K, Huang J, Johnson-Wood K, Khan K, Kholodenko D, Lee M, Liao Z, Lieberburg I, Motter R, Mutter L, Soriano F, Shopp G, Vasquez N, Vandevert C, et al. (1999) Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse. Nature 400:173-177.
33. Selkoe DJ, Hardy J (2016) The amyloid hypothesis of Alzheimer's disease at 25 years. EMBO Mol Med 8:595-608.
34. Sevigny J, Chiao P, Bussière T, Weinreb PH, Williams L, Maier M, Dunstan R, Salloway S, Chen T, Ling Y, O'Gorman J, Qian F, Arastu M, Li M, Chollate S, Brennan MS, Quintero-Monzon O, Scannevin RH, Arnold HM, Engber T, et al. (2016) The antibody aducanumab reduces Abeta plaques in Alzheimer's disease. Nature 537:50-56.
35. Shankar GM, Li S, Mehta TH, Garcia-Munoz A, Shepardson NE, Smith I, Brett FM, Farrell MA, Rowan MJ, Lemere CA, Regan CM, Walsh DM, Sabatini BL, Selkoe DJ (2008) Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory. Nat Med 14:837-842.
36. Smits LL, Liedorp M, Koene T, Roos-Reuling IE, Lemstra AW, Scheltens P, Stam CJ, van der Flier WM (2011) EEG abnormalities are associated with different cognitive profiles in Alzheimer's disease. Dement Geriatr Cogn Disord 31:1-6.
37. Sperling RA, Aisen PS, Beckett LA, Bennett DA, Craft S, Fagan AM, Iwatsubo T, Jack CR Jr, Kaye J, Montine TJ, Park DC, Reiman EM, Rowe CC, Siemers E, Stern Y, Yaffe K, Carrillo MC, Thies B, Morrison-Bogorad M, Wagster MV, et al. (2011) Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 7:280-292.
38. Strittmatter WJ, Saunders AM, Schmechel D, Pericak-Vance M, Enghild J, Salvesen GS, Roses AD (1993) Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci U S A 90:1977-1981.
39. Thies W, Bleiler L (2013) Alzheimer's disease facts and figures. Alzheimers Dement 7:208-244.
40. Vassar R, Bennett BD, Babu-Khan S, Kahn S, Mendiaz EA, Denis P, Teplow DB, Ross S, Amarante P, Loeloff R, Luo Y, Fisher S, Fuller J, Edenson S, Lile J, Jarosinski MA, Biere AL, Curran E, Burgess T, Louis JC, et al. (1999) Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE. Science 286:735-741.
41. Young JE, Goldstein LS (2012) Alzheimer's disease in a dish: promises and challenges of human stem cell models. Hum Mol Genet 21:R82-89.